Hypoglycemia associated with high doses of sertraline and sulphonylurea compound in a noninsulin-dependent diabetes mellitus patient

Canadian Journal of Clinical Pharmacology

Volumn 6, Issue 1, 1999, Pages 12-14

  Takhar, Jatinder ^a   Williamson, Peter ^b  

^a London Psychiatric Hospital   (Canada)

^b NONE

Author keywords

Cytochrome P450 system; Glyburide; Hypoglycemia; Noninsulin dependent diabetes mellitus; Sertraline

Indexed keywords

CYTOCHROME P450; GLIBENCLAMIDE; GLUCOSE; ORAL ANTIDIABETIC AGENT; PSYCHOTROPIC AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SULFONYLUREA;

ADULT; ARTICLE; CASE REPORT; DIABETES CONTROL; DRUG BLOOD LEVEL; DRUG MEGADOSE; DRUG METABOLISM; DRUG WITHDRAWAL; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SCHIZOIDISM;

EID: 0032950097     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Pollock BG. Recent developments in drug metabolism of relevance to psychiatrists. Harv Rev Psychiatry 1994;2:204-13.
2. Compendium of Pharmaceuticals and Specialties, 32nd edn. Ottawa: Canadian Pharmaceutical Association, 1997.
3. Hales RE, Yudofsky SC, Talbot JA. Textbook of Psychiatry, 2nd edn. Washington: The American Psychiatric Press, 1994.
4. Blume FE, Kupfer DJ, Bunney BS, et al, eds. Psychopharmacology: the fourth generation of progress. New York: Raven Press Limited, 1995.
5. Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996;153:311-20.
6. von Rosenstiel NA, Adam D. Macrolide antibacterials, drug interactions of clinical significance. Drug Saf 1995;13:105-22.
7. Preskorn SH, Magnus RD. Inhibition of hepatic P-450 isoenzymes by serotonin selective reuptake inhibitors: in vitro and in vivo findings and their implications for patient care. Psychopharmacol Bull 1994;30:251-9.
8. Rapeport WG, Williams SA, Muirhead DC, Dewland PM, Tanner T, Wesnes K. Absence of a sertraline-mediated effect on the pharmacokinetics and pharmacodynamics of carbamazepine. J Clin Psychiatry 1996;57:20-3.
9. Ketter TA, Flockhart DA, Post RM, et al. The emerging role of cytochrome P450 3A in psychopharmacology. J Clin Psychopharmacol 1995;15:387-98.
10. Goldberg RJ. The P-450 system: Definition and relevance to the use of antidepressants in medical practice. Arch Fam Med 1996;5:406-12.
11. Ayd FJ Jr. International Drug Therapy Newsletter 1995;30:5-11.
12. Eli Lilly Canada Inc. Making reintegration the goal prescribing information. Product Monograph. Scarborough: Eli Lilly Canada Inc, 1998.